Thiourea and Related Compounds in the Treatment of Hyperthyroidism * by Winkler, A. W. & Danowski, T. S.
THIOUREA AND RELATED COMPOUNDS IN THE
TREATMENT OF HYPERTHYROIDISM*
A. W. WINKLER AND T. S. DANOWSKI
The use of thyroid-depressant agents in the control of hyper-
thyroidism has raised questions concerning their relationship to other
goitrogens and their mode of action. Other problems have been
encountered as well, particularly with respect to toxic reactions, the
effect of preliminary iodine administraton, and the control of the
hypothyroid state which may result. The information available on
these subjects has, therefore, been analyzed critically, and the rela-
tive merits of thyroidectomy and of medical treatment of hyperthy-
roidism are discussed.
Types of goiter. More than a quarter of a century ago Marine
and Kimball49 demonstrated that endemic goiter could be prevented
by the administration of iodine. In the two decades prior to 1941
it was possible to assert that all nontoxic goiter was due to an insuf-
ficient supply of iodine. This statement was based on the observa-
tion that iodine counteracted the effects of all known goitrogenic
diets. Thus, simultaneous administration of iodine prevented the
development of goiters in animals fed winter cabbage'6 74, 576, 77
and in those fed soy-bean flour.70' 71, 78 Further investigation had
proven that a number of pure organic cyanides and thiocyanates were
goitrogenic,9'
" 61 and that their action was also preventable by
iodine.48 Since organic cyanides and cyanogens48 are regular con-
stituents of winter cabbage and of soy-beans, it was concluded that
these compounds were responsible for the goitrogenic action.
Means,5' writing in 1936, asserted: "Thus cabbage goiter is cyanide
goiter, and cyanide goiter is iodine-want goiter conditioned by an
increased secretory demand placed upon the thyroid gland by a
retarded tissue oxidation resulting from the action of hydrogen
cyanide."
In 1941 a type of goiter was discovered whose production could
not be prevented bylarge doses of iodine. The goiter was produced
byfeeding Brassica seeds and rape seeds.32",' 3 These plants belong
to the ca-bbage family, but the effects were not due to any cyanides
which they might contain. The active agent was thought by Ken-
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nedy to be a thiourea derivative.38 Allyl-thiourea was found, in fact,
to produce a goiter entirely similar in character to that seen after
the ingestion of rape seed. Independently in the same year Richter
and Clisby,67 studying the general toxicity of phenylthiourea (phen-
ylthiocarbamide), reported a goitrogenic action.
Mackenzie, Mackenzie, and McCollum47 found, in 1941,
another class of compounds, the sulfonamides, to be goitrogenic
despite a high intake of iodine. Sulfaguanidine was the most effec-
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the thioureas) possessed similar goitrogenic properties (Fig. 1).
Treatment of animals with these substances produced a fall in the
basal meta-bolic rate3' 45, 46, 47 and histological changes in the pituitary
closely resembling those which follow thyroidectomy.46 Using the
rat as a test animal, thiouracil appeared to be the most potent
thyroid-depressant in all 3 series of compounds.3
The albility of substances of this new type to induce hypothy-
roidism with great regularity clearly separates their action from that
of the various cyanides and other goitrogenic diets. The demarca-
tion is, however, by no means absolute. Although diets deficient
in iodine, or containing cyanide, do not commonly cause hypothy-
roidism, there are certain exceptions. Deficiency of iodine in the
maternal diet may produce endemic cretinism.5' Furthermore,
hypothyroidism in thiocyanate goiter of man has been reported.6'
Functional depression occurs, however, onlysporadically and is easily
prevented by iodine administration. Moreover, within a certain
range of dosage, intermediate between ineffective and fully effective
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amounts, simultaneous administration of iodine has an action mark-
edly antagonistic to that of thiouracil in normal rats. Conversely,
iodine deficiency favors the action of thiouracil in small doses.4
Mechanism of action. Under thiourea, thiouracil, or suffona-
mide treatment the iodine content of the thyroid gland decreases
rapidly.5 12 Studies with radio-aotive iodine have demonstrated
conclusively that inorganic iodine can enter the thyroid gland in
the presence of these compounds, but is not synthesized into diio-
dotyrosine or thyroxine.4 25, 26 27, 28, 37, 40, 63 These substances pro-
duce hypothyroidism, therefore, by blocking the formation of
thyroid hormone. They do not interfere with the release of hor-
mone aliready present in the gland.
Peripheral utilization of thyroid hormone is not affected signifi-
cantly, if at all, since desiccated thyroid or thyroxine prevents both
the hypometabolism and the glandular hyperplasia.22' 5 No direct
effect on tissue metabolism has been reported as yet, other than that
which results from depression of the thyroid gland. On the other
hand, the onset of the hypometabolic state in rats can be accelerated
by lowering the temperature of the environment.22 The animals
are then far more susceptible to the action of thiouracil as a result
of the greater demand for thyroid hormone in a cold environment.
The goiter which develops is mediated through the pituitary
gland, since hypophysectomy prevents the thyroid hyperplasia even
though the metabolism is profoundly depressed by thiourea or
thiouracil.7' 46 An intact pituitary gland is necessary, since injection
of pituitary extract into hypophysectomized-thiouracilized rats is not
followed 'by goiter formation. It has been shown by Gordon and
his co-workers that the thyroid becomes hyperplastic as a result of
increased pituitary secretion of thyrotropic hormone.3' This can be
demonstrated only under specific experimental conditions, since the
thyroid gland possesses an extraordinary avidity for thyrotropic
hormone. This prevents an increase in the amount present in the
circulation. Thiouracil does not enhance the activity of thyrotropic
hormone.40 These interrelationships are shown in Fig. 2. Clinical
studies support this interpretation. Hyperthyroid patients under
thiourea treatment develop low concentrations of serum iodine, indi-
cating that the output of thyroid hormone is reduced.20' 42
Conclusive experiments are lacking as to the exact mechanism
whereby the synthesis of thyroid hormone is abolished. Hundreds
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of compounds have now been tested for thyroid-depressant activity
not preventable by iodine.6 All of the effective drugs possess either
a thiocarbamide or an aminobenzene group. Astwood has suggested
that the reducing powers of the!=-C=S portion of the thiocarbamide
molecul-e are important. This theory fails to explain, however, the
activity of the aminobenzenes which lack this group. Lerner and
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Fig. 2. Mechanism of goiter productioni during thiourea anld thiouracil treatment.
Chaikoff have shown that thiourea is without effect on the cyto-.
chrome-cytochrome oxidase system.4
It has been found in dog experiments that thiourea exerts its
thyroid-depressant effect wi'thout undergoing destruction in measur-
able amounts in the gland. The thiourea which is not recovered in
uFrine is apparently destroyed in the kidney, and in no other tissue.'8
This suggests that thiourea stops the elaboration of thyroid hormone
either by its simple presence in the gland, or by entering into a
reversible combination with some component of t ththyroid tissue.
It is also pertinent that it has not been possible to demonistrate any
particular avidity of the thyroid gland for thiourea. The drug is
not concentrated in the gland inamountts greater tihan those which
would be expected from its concentration in body water as a whole.'8
The metabolism tof thiouracil, however, differs fromthat of thiourea,
since it is destroyed in practically all body tissues.8' The highdest
concentrations of this drug have been found in the bone-marrow.
This may well be responsible for the marked tendency of this drug
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to produce depression of the bone-marrow. Thiourea may ulti-
mately, therefore, prove to 'be a safer agent in this respect.
Any theory of the action of these substances must account for
their effectiveness in very small amounts when given once daily in
the treatment of hyperthyroidism.20 It should be remembered,
however, that the demonstration that thiourea and thiouracil depress
the thyroid gland does not preclude some peripheral action as well.
If, as has been suggested, there is extrathyroidal production of
thyroid hormone, thiourea and thiouracil may prevent the formation
of this moiety as well.
Clinical experience with thiouracil and thiourea. The first
account of clinical success was that of Astwood2 in 1943, using
both thiourea and thiouracil. Since then the effectiveness of these
and similar drugs in hyperthyroidism has been abundantly con-
firmed.1' 8, 10, 11, 13, 15, 17, 20, 23, 24, 29, 35, 43, 44, 55, 57, 58, 59, 60, 66, 68, 73, 79, 80
Certain facts are now established. These may be briefly summarized:
(1) The great majority of cases of hyperthyroidism will respond
with a drop in basal metabolism and in serum precipitable iodine
with concomitant clinical improvement. Partially refractory cases
are occasionally encountered. Patients with toxic adenomata as well
as those with diffuse goiter improve under treatment.
(2) The time required for the return to a normal metabolic
status is variable. Four to six weeks is the most common interval.
(3) The dose necessary to bring atbout and maintain a remission
varies somewhat from one case to another. The customary dose of
thiouracil has been 0.6 gm. daily, and of thiourea from 0.3 to
0.1 gm. Smaller amounts of each drug have, however, been
effective. Irrespective ofthedose acertain time interval is necessary
before the drug is fully effective.
(4) Continued administration of the drug frequently produces
hypothyroidism, with subnormal levels of the metabolic rate and of
the serum iodine. Desiccaited thyroid will prevent or correct the
hypothyroidism.
(5) Discontinuance of the drug within the first year may result
in an exacerbation of the hyperthyroidism, but in some cases the
remission persists after medication is interrupted. The longer the
drug is continued the larger the proportion of persistent remissions.
(6) Thiouracil, the substance used by most observers, produces
a toxic reaction in about 13 per cent of the cases.54 72 Leukopenia
develops in over 4 per cent of the cases and granulocytopenia in 2.5
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per cent. The granulocytopenia leads to a fatal agranulocytosis in
about one case in 200. Discontinuance of the thiouracil followed
by penicillin treatment will save some patients.69 The agranulocy-
tosis usually occurs during the first 3 months but may appear after
as much as 8 months of treatment; no reliable warning sign has been
noted.
Thiourea used in large amounts, 1 to 3 gm. daily, produced hali-
tosis, nau!sea, vomiting, skin eruptions, fever, and rarely leuko-
penia.35 56 Smaller amounts, 75 to 300 mg. daily, have eliminated
most ofthese reactions. Drug fever, however, has been encountered
in 2 of 54 cases.20 Agranulocytosis has not been reported with this
drug nor with propylthiouracil.8 The experience with these com-
pounds, however, is limited.
(7) Pregnancy does not appear to be a contraindication to treat-
ment of hyperthyroidism with thiouracil or thiourea, despite the
findings of Hughes,36 and of Goldsmith, Gordon, and Charipper30
in rat experiments. The fetus developed a hyperplastic thyroid
gland and the growth of the offspring was retarded. These effects
probably resulted from the transmission of the drug through the
placenta and, later, through the maternal milk.
Hyperthyroidism has been successfully treated, however, during
human pregnancy without any evident ill effect upon the child.79
Cretinism will probably not develop if hypothroidism is avoided.
It must be pointed out that during pregnancy an increase in the
serum precipitable iodine may be observed.34 Since this is not
associated with stigmata of hyperthyroidism it is thought to be physi-
ological. This development must be differentiated from true hyper-
thyroidism, lest the patient be given thyroid-depressant drugs
unnecessarily.
Role of iodine in the response to thyroid-depressant agents.
Astwood's demonstration in rats that within a certain range of thiou-
racil dosage iodine may delay the response has deeply influenced
clinical thinking concerning the simultaneous use of these two drugs
in the treatment of patients with hyperthyroidism. This is not
wholly logical, since the effects of iodine therapy in hyperthyroidism
are quite different from those in normal subjects. There is a wide-
spread belief that preliminary medication with iodine delays the
action of thiouracil in*hyp;erthyroidism. This has been ascribed to
the interval needed for degradation of extra hormone stored during
the period of iodine medication. On the other hand, iit has been rec-
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ognized thatiodine may reduce the hyperplasia induced by thiouracil.
Thus thiouracil alone is an unsatisfactory pre-operative agent because
of the intense hyperplasia and vascularity ofthe gland, but treatment
first with thiouracil and then with ioodine will produce a surgically
much more manageable gland.17'62 The independence of the effects
of iodline and of thiouracil has recently been clearly demonstrated by
Rawson and his associates.62 They treated hyperthyroid subjects
with thiouracil alone for a time, then supplemented this with a
course of iodine medication. Biopsies of the gland were obtained
at intervals. They found that the initial hyperplasia of the thyroid
gland in Graves' disease was greatly intensified by thiouracil alone,
although metabolism fell and the gland lost much of its iodine. The
administration of iodine in addition to thiouracil was followed by
marked iresolution of the hypexplasia, although no iodine was stored
in the gland. This evidence clearly separates the action of iodine
in the reduction ofglandular hyperplasia from its action in increasing
the storage of iodine by the gland, and thus disposes of any unitary
theory of the action of iodine in Graves' disease. It also indicates
differing actions by thiouracil and by iodine in Graves' disease,
although both actions are inhibitory in character. Rawson believes
that the iodine in some way blocks the action of thyrotropic hormone
on the gland, while thiouracil simply bars iodine from elaboration
into complex organic form. This explanation presupposes a block-
age by iodine of an excess of thyrotropic hormone without inter-
ference with the action of normal amounts of thyrotropic hormone,
since in normal subjects iodine is without demonstrable effect on the
output of thyroid hormone. This hypothesis is as yet unproven.
Practically every clinical report has noted that cases which had
been previously receiving iodine took from 60 to 100 days for the
basal to return to normal, whereas a period of 30 or 40 days was the
usual time in other cases. Danowski, Man, and Winkler, on the
basis of clinical observations,'9 have recently questioned the existence
of an antagonistic effect ofiodine on thiourea activity.* They found
that if iodine was given prior to thiourea in unselected cases and
then was continued during the period of thiourea medication, the
* Thiourea, rather than thiouracil, was used throughout, because it is at least as
effective as thiouracil or any of its known derivatives5' 20 and is probably less toxic.
Astwood originally selected thiouracil rather than thiourea for extensive clinical trial
because of its greater goitrogenic potency in the normal rat. The human patient
with hyperthyroidism reacts differently, however.
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rate of fall was on the average no different from that of unselected
cases treated with thiourea alone. If thiourea and iodine were given
simultaneously, the rate of fall of serum precipitable iodine and
basal metabolism was somewhat more rapid than that following
thiourea alone. Three possible explanations of this apparent dis-
crepancy exist. First, it may be a difference between thiourea and
thiouracil. Since their action on the thyroid gland is the same, this
appears unlikely. Second, these workers continued the iodine medi-
cation after thiourea was started whereas most previous workers had
discontinued the iodine when thiouracil was started because of a
supposed antagonism as reported experimentally in rats.4 Third,
patients in this series were treated at random, some with and some
without iodine, before the thiourea was commenced. The majority
olf the cases reported in the literature and cited as showing delay
were those who had received iodine medication for a long time and
in whom hyperthyroidism still remained very active; they were thus
a peculiarly selected group of cases. Danowski and co-workers
showed that in certain cases in whom a remission had been obtained
while the patient was on both iodine and thiourea, omission of the
iodine produced an exacerbation of the hyperthyroidism before the
thiourea had taken full effect. In other words, the result actually
noted is a combination of escape from iodine inhibition superimposed
upon a direct thiouracil effect. The condusion seems reasonably
justified that iodine and thioureamedication supplement one aniother,
and that, in general, both should be used together.
Control of hypothyroidism produced by thiouracil or thiourea.
The hypothyroidism which develops during the course of prolonged
thiourea therapy can be prevented by thyroid or thyroxine medica-
tion or by reduction in ithe dosage of thiourea."9 20, 58 There is no
apparent advantage of thyroxine over thyroid and its intravenous
administration obviously makes it much less practical. Whichever
method is used there is a tendency to alternate between hypothy-
roidism due to excessive dosage and relapse of 'the hyperthyroidism.
The matter is further complicated by the fact that, as time goes on
in the course of thiourea medication, progressively smaller doses
will serve to maintain the patient in remission, and continuance of
the same dose which was at first necessary to control the hyper-
thyroidism may, after some weeks, regularly produce hypothyroid-
ism. Avoidance of these complications by either method requires
continuous observation. The basal metabolism may be somewhat
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misleading since the metabolism may remain within normal range
for a considerable period after the serum precipitable iodine has
fallen to subnormal values and symptoms of hypothyroidism
develop.'9, 20 It is particularly unfortunate if, as seems likely, hypo-
thyroidism favors progression of exophthalmos.52
The dose ofthyroid necessary to prevent hypothyroidism is quite
variable both among patients and at different times in the same
patient.'9 This may be due to a number of faotors but one of them
may well be the variable degree of inactivation of the hormone.
Dempsey and Astwood have assumed that the minimum amount olf
thyroid necessary to prevent the goitrogenic activity of thiouracil in
the normal animal is equal to the daily maintenance requirement of
hormone.22' 64, 65 This assumption implies that none of the adminis-
tered hormone is inactivated and so is probably not wholly justified.
The inconsistency of the results obtained by different workers using
this method of assay and the evidence from other sources that inacti-
vation of administered hormone may take place is strong evidence
against the validity of the basic assumption.2'
Treatment of hyperthyroidism by thyroidectomy and by thyroid-
depressant drugs. During the years preceding the introduction of
thyroid-depressant drugs thyroid surgery had progressed to a high
state of technical perfection. The operative mortality with subtotal
thyroidectomy following preliminary treatment with iodine has been
reduced to less than one per cent under favorable circumstances.
The operative mortality is higher than this, however, if the series
includes a high proportion of elderly patients with cardiovascular
and other complications. Several disadvantages are inherent, how-
ever, in the surgical treatment of hyperthyroidism apart from the
immediate operative risk. Accidental injury to the laryngeal nerve
and to the parathyroid glands is occasionally inescapable. More
common is the failure of -the operation to achieve a permanent cure
of the hyperthyroidism. For example, in one reoenit series 7 per
cent had recurred within 18 months.79 Experience indicates that
the percentage of recurrences will increase with the passage of time.
The incidence of re-currences may be reduced by a more radical
removal of the gland, but with this type of operation the percentage
of cases olf persistent hypothroidism is increased.82
Treatment with thiouracil, thiourca, and their derivatives elimi-
nates all the surgical risks of thyroidectomy, but substitutes the risks
of toxic reactions to the drugs themselves. Some type of toxic reac-
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tions occurs in 13 per cent of all patients treated with thiouracil,
induding leukopenia in 5 per cent and agranulocytosis in about 1
per cent of the patients treated. The incidence may be somewhat
less with other thyroid-depressant drugs.8 19 These unfavorable
reactions are most frequent during the first few weeks of treatment,
but may occurat any time thereafter. In any one patient, therefore,
the risk of atoxic reaction increases the longer the drug is continued.
lnterruption of medication favors toxic reactions when the drug is
again taken.
Discontinuance of treatment with thiouracil after the first few
months results in an early relapse of the hyperthyroidism in about
half of the cases.79 The longer the drug is continued, the lower the
percentage of relapses. Apart from the liability to toxic reactions,
this tendency to relapse with interruption of treatment is the most
serious limitation to the practical employment of the antithyroid
drugs. The tendency to develop hypothyroidism if the dosage is
not wisely adjusted constitutes another complication of this form of
prolpnged medical therapy. Whether the prolonged use of these
substances may lead to the development of carcinoma remains
unsettled.'4
The high proportion of permanent cures which follow skillful
thyroid surgery makes this procedure still a suitable form of treat-
ment in hyperthyroidism. Prolonged medical treatment with cer-
tain of the thyroid-depressant drugs has also proven satisfactory.
The discovery in the near future of safer drugs than thiouracil may
confidently 'be predicted. With thisdevelopment the role of medical
therapy can be greatly expanded.
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